{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:36:19Z","timestamp":1714696579880},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.7759\/cureus.59490","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T04:42:02Z","timestamp":1714624922000},"source":"Crossref","is-referenced-by-count":0,"title":["Perioperative Use of Levosimendan in Hepatic Transplantation With Diastolic Heart Failure: A Case Report"],"prefix":"10.7759","author":[{"given":"Erick","family":"Villaf\u00e1n V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Acu\u00f1a Razo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra Michelle","family":"Nu\u00f1ez Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X14666180322104015","article-title":"Levosimendan for perioperative cardioprotection: myth or reality?","volume":"14","author":"Santillo E","year":"2018","unstructured":"Santillo E, Migale M, Massini C, Incalzi RA. Levosimendan for perioperative cardioprotection: myth or reality?. Curr Cardiol Rev. 2018, 14:142-52. 10.2174\/1573403X14666180322104015","journal-title":"Curr Cardiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfn045","article-title":"Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE","volume":"11","author":"Mebazaa A","year":"2009","unstructured":"Mebazaa A, Nieminen MS, Filippatos GS, et al.. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE. Eur J Heart Fail. 2009, 11:304-11. 10.1093\/eurjhf\/hfn045","journal-title":"Eur J Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd10080332","article-title":"The perioperative use of levosimendan as a means of optimizing the surgical outcome in patients with severe heart insufficiency undergoing cardiac surgery","volume":"10","author":"Leivaditis V","year":"2023","unstructured":"Leivaditis V, Grapatsas K, Papaporfyriou A, et al.. The perioperative use of levosimendan as a means of optimizing the surgical outcome in patients with severe heart insufficiency undergoing cardiac surgery. J Cardiovasc Dev Dis. 2023, 10:10.3390\/jcdd10080332","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.02.022","article-title":"Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion","volume":"184","author":"Toller W","year":"2015","unstructured":"Toller W, Heringlake M, Guarracino F, et al.. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol. 2015, 184:323-36. 10.1016\/j.ijcard.2015.02.022","journal-title":"Int J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.04.243","article-title":"Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden","volume":"175","author":"Thorvaldsen T","year":"2014","unstructured":"Thorvaldsen T, Benson L, Hagerman I, Dahlstr\u00f6m U, Edner M, Lund LH. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden. Int J Cardiol. 2014, 175:55-61. 10.1016\/j.ijcard.2014.04.243","journal-title":"Int J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2006.04.012","article-title":"Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure","volume":"9","author":"Lilleberg J","year":"2007","unstructured":"Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur J Heart Fail. 2007, 9:75-82. 10.1016\/j.ejheart.2006.04.012","journal-title":"Eur J Heart Fail"},{"key":"ref8","article-title":"Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion","volume":"145","author":"Vollmar B","year":"1994","unstructured":"Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol. 1994, 145:1421-31.","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187839","article-title":"Levosimendan protects human hepatocytes from ischemia-reperfusion injury","volume":"12","author":"Brunner SN","year":"2017","unstructured":"Brunner SN, Bogert NV, Schnitzbauer AA, et al.. Levosimendan protects human hepatocytes from ischemia-reperfusion injury. PLoS One. 2017, 12:e0187839. 10.1371\/journal.pone.0187839","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207972-perioperative-use-of-levosimendan-in-hepatic-transplantation-with-diastolic-heart-failure-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T04:42:06Z","timestamp":1714624926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207972-perioperative-use-of-levosimendan-in-hepatic-transplantation-with-diastolic-heart-failure-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.59490","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}